Abstract
In this chapter, we review the discovery of MAP30, a novel multifunctional antiviral and anti-tumor plant protein, and elucidation of its medicinal properties. MAP30, M omordica A ntiviral P rotein 30 kD, is isolated from the medicinal plant Momordica charantia. Biochemical and biophysical studies have yielded important insights into the structure, function and mechanism of MAP30. Column chromatography by ionic exchange, affinity binding and size fractionation were applied for the isolation and purification of MAP30. Protein and nucleotide sequencing were used to elucidate the structure of this protein and its gene. The gene encoding MAP30 was cloned and expressed by recombinant technology. Structure activity mapping was performed using 3D-structure determination, bioinformatics and molecular modeling, together with bioactivity confirmation. Results from these studies demonstrate how cutting-edge modern approaches can be applied to discover medicinal activities from natural products and to define their molecular structure, biological function, and mechanisms of action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Robinson MM, Zhang X (2011) Traditional medicines, issues and challenges. WHO, Geneva
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey SA, Van Rompay M, Kessler RC (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575
Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246–252
Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS (2002) Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey. Arch Intern Med 162(3):281–287
Eisenberg DM, Kessler RC, Van Rompay MI, Kaptchuk TJ, Wilkey SA, Appel S, Davis RB (2001) Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 135(5):344–351
Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ, Eisenberg DM (2001) Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 135(4):262–268
Nahin RL, Barnes PM, Stussman BJ, Bloom B (2009) Cost of CAM and frequency of visits to CAM prectitioners: United States, 2007 National health statistics reports; no 18. National Center for Health Statistics, Hyattsville
Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun YT, Chang Y-T, Zhang J, Huang PL (2007) Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. Fusion inhibition. Biochem Biophys Res Commun 354:872–878
Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun YT, Chang Y-T, Zhang J, Huang PL (2007) Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part II. Integrase inhibition. Biochem Biophys Res Commun 354:879–884
Bao J, Zhang DW, Zhang JZH, Huang PL, Huang PL, Lee-Huang S (2007) Computational study of bindings of olive leaf extract (OLE) to HIV-1 fusion protein gp41. FEBS Lett 581:2737–2742
Lee-Huang S, Zhang L, Huang PL, Chang YT, Huang PL (2003) Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun 307:1029–1037
Lee-Huang S, Maiorov V, Huang PL, Lee HC, Ng A, Chang Y-T, Kallenbach N, Huang PL, Chen HC (2005) Structural and functional modeling of human lysozyme reveals a unique nonapeptide, HL9, with anti-HIV activity. Biochemistry 44:4648–4655
Lee-Huang S, Huang PL, Huang PL, Sun YT, Kung HF, Blithe DL, Chen HC (1999) Lysozyme and ribonucleases as anti-HIV components in beta-core preparations of hCG. Proc Natl Acad Sci U S A 96:2678–2681
Bourinbaiar AS, Lee-Huang S (1995) Anti-HIV effect of beta subunit of human chorionic gonadotropin (βhCG) in vitro. Immunol Let 44:13–18
Lee-Huang S, Huang PL, Nara PL, Chen HC, Kung HF, Huang P, Huang HI, Huang PL (1990) MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Letts 272:12–18
Lee-Huang S, Huang PL, Kung HF, Li BQ, Huang PL, Huang P, Huang HI, Huang PL, Chen HC (1991) TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells. Proc Natl Acad Sci U S A 88:6570–6574
Lee-Huang S, Kung HF, Huang PL, Huang PL, Li B-Q, Huang P, Huang HI, Chen HC, Huang PL (1991) A new class of anti-HIV agents: GAP 31, DAP 30 and DAP 32. FEBS Letts 291:139–144
Huang PL, Sun YT, Chen HC, Huang PL, Lee-Huang S (1999) Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active. Biochem Biophys Res Commun 262:615–623
Lee-Huang S, Huang PL, Chen HC, Huang PL, Bourinbaiar AS, Huang HI, Kung HF (1995) Anti-HIV and anti-tumor activities of recombinant MAP 30 of bitter melon. Gene 161:151–156
Arazi T, Huang PL, Huang PL, Zhang L, Shiboleth YM, Gal-On A, Lee-Huang S (2002) Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV–AGII. Biochem Biophys Res Commun 292:441–448
Rybak SM, Lin JJ, Newton DL, Kung HF, Monks A, Chen HC, Huang PL, Huang PL, Lee-Huang S (1994) In vitro anti-tumor activity of the plant ribosome inactivating proteins MAP 30 and GAP 31. Int J Onc 5:1171–1176
Lee-Huang S, Huang PL, Sun YT, Kung HF, Huang PL, Murphy WJ (2000) Inhibition of human breast tumor MDA-MB-231 xenografts and HER2 expression in SCID mice by anti-tumor agents GAP31 and MAP30. Anticancer Res 20:653–659
Lee-Huang S, Huang PL, Chen HC, Kung HF, Nara PL, Li BQ, Huang PL, Huang HI, Huang PL (1992) Plant proteins with antiviral activity against HIV. In: Chu CK, Cutler HG (eds) Natural products as antiviral agents. Plenum, New York, pp 153–170
Schreiber CA, Sun YT, Wan L, Krey LC, Lee-Huang S (1999) Anti-HIV agents, MAP30 and GAP31 are not toxic to human spermatocytes: potential use of these agents against sexual transmission of HIV-1. Steril Ferti 72:686–690
Lee-Huang S, Huang PL, Kong XP, Schapira M, Huang PL (2003) Novel anti-HIV and anti-tumor proteins MAP30 and GAP31: molecular, biochemical and structural insights into biological activities and mechanism. Recent Res Devel Biophys Biochem 81:235–257
Bourinbaiar AS, Lee-Huang S (1995) Potentiation of anti-HIV activity of anti-inflammatory drugs dexamethasone and indomethacin, by MAP 30, the antiviral agent from bitter melon. Biochem Biophys Res Commun 208:779–785
Bourinbaiar AS, Lee-Huang S (1996) The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus infection in vitro. Biochem Biophys Res Commun 219:923–929
Sun YT, Huang PL, Li JJ, Huang YQ, Zhang L, Huang PL, Lee-Huang S (2001) Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with kaposi’s sarcoma-associated virus. Biochem Biophys Res Commun 287:983–994
Huang PL, Chen HC, Kung HF, Huang PL, Huang P, Huang HI, Lee–Huang S (1992) Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms. BioFactors 4:37–41
Lee-Huang S, Kung HF, Huang PL, Bourinbaiar AS, Morell JL, Brown JH, Huang PL, Tsai WP, Chen AY, Huang HI, Chen HC (1994) HIV-1 inhibition, DNA binding, RNA binding and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP 31. Proc Natl Acad Sci U S A 91:12208–12212
Lee-Huang S, Huang PL, Huang PL, Bourinbaiar AS, Chen HC, Kung HF (1995) Inhibition of HIV-1 integrase by plant antiviral proteins MAP 30 and GAP 31. Proc Natl Acad Sci U S A 92:8818–8822
Lee-Huang S, Kung HF, Chen HC, Huang PL, Rybak SM, Huang PL, Bourinbaiar AS, Musayev F, Liaw YC (1994) Crystallization and preliminary X-ray analysis of GAP 31: an anti-HIV protein. J Mol Biol 240:92–94
Wang YX, Nouri N, Jacob J, Palmer I, Stahl SJ, Kaufman JD, Huang PL, Huang PL, Heather E, Pommier Y, Wingfield PT, Lee-Huang S, Bax A, Torchia DA (1999) Solution structure of anti-HIV and anti-tumor protein MAP30: structural insights into its multiple functions. Cell 99:433–442
Wang YX, Jacob J, Wingfield PT, Palmer I, Stahl SJ, Kaufman JD, Huang PL, Huang PL, Lee-Huang S, Torchia DA (2000) Anti-HIV and anti-tumor protein MAP30, a 30 kDa single strand type-1 RIP, shares similar secondary structure and β-sheet topology with the A chain of ricin, a type-II RIP. Prot Sci 9:138–144
Wang XY, Marquardt J, Wingfield P, Stahl SJ, Lee-Huang S, Torchia D, Bax A (1999) Simultaneous measurement of 1H–15N, 1H–13C′ and 15N–13C′ dipole coupling in a perdeuterated 30 kDa protein dissolved in a dilute liquid crystalline phase. J Am Chem Soc 120:7385–7386
Wang XY, Jacob J, Cordier F, Wingfield P, Stahl SJ, Lee-Huang S, Torchia D, Grzesiek S, Bax A (1999) Measurement of (3 h)J(NC′) connectivities across hydrogen bonds in a 30 kDa protein. J Biomol NMR 14:181–184
Huang PL, Huang PL, Lee-Huang S (2010) Oleuropein and related compounds reduce atherosclerosis. Open Conf Proc J 1:81–86
Lee-Huang S, Huang PL, Zhang D, Zhang JZH, Huang PL (2012) Oleuropein and related compounds from olive plants modulate adipogenesis. Open Conf Proc J (in press)
Hartono YD, Lee AN, Lee-Huang S, Zhang D (2011) Computational study of bindings of HL9, a nonapeptide fragment of human lysozyme, to HIV-1 fusion protein gp41. Bioorg Med Chem Lett 21:1607–1611
Lee-Huang S, Huang PL, Huang PL (2011) Live-cell real-time imaging reveals role of mitochondria in cell-to-cell transmission of HIV-1. Biochem Biophys Res Commun 415(2):384–389
Fang EF, Zhang CZ, Wong JH, Shen JY, Li CH, Ng TB (2012) The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. Cancer Lett 324(1):66–74 (Epub 9 May 2012)
Meng Y, Liu S, Li J, Meng Y, Zhao X (2012) Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica charantia L. with covalent conjugation of polyethyelene glycol. Int J Nanomed 7:3133–3142 (Epub 27 June 2012)
Acknowledgments
Work done in this review was supported in part by NIH grants R01 AI31343, R01 AT01383, and by Blackout Funding. The authors are grateful to Helen C. Lin for her support and encouragement.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
This Chapter is dedicated to the memory of Professor Severo Ochoa, our adored mentor, and to Dr. An Fu Lee, our beloved mother and grandmother, for their inspiration and encouragement.
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Lee-Huang, S., Lin Huang, P., Lee Huang, P. (2013). The Discovery of MAP30 and Elucidation of its Medicinal Activities. In: Fang, E., Ng, T. (eds) Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6214-5_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-6214-5_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6213-8
Online ISBN: 978-94-007-6214-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)